Display options
Cite
Hooper JE, Cantor EL, Ehlen MS, et al. A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies. Sarcoma. 2015;2015:826124doi: 10.1155/2015/826124.
Hooper, J. E., Cantor, E. L., Ehlen, M. S., Banerjee, A., Malempati, S., Stenzel, P., Woltjer, R. L., Gandour-Edwards, R., Goodwin, N. C., Yang, Y., Kaur, P., Bult, C. J., Airhart, S. D., & Keller, C. (2015). A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies. Sarcoma, 2015826124. https://doi.org/10.1155/2015/826124
Hooper, Jody E, et al. "A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies." Sarcoma vol. 2015 (2015): 826124. doi: https://doi.org/10.1155/2015/826124
Hooper JE, Cantor EL, Ehlen MS, Banerjee A, Malempati S, Stenzel P, Woltjer RL, Gandour-Edwards R, Goodwin NC, Yang Y, Kaur P, Bult CJ, Airhart SD, Keller C. A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies. Sarcoma. 2015;2015:826124. doi: 10.1155/2015/826124. Epub 2015 Nov 30. PMID: 26696773; PMCID: PMC4677247.
Copy Download .nbib Format: NLM
Share it on

Sarcoma. 2015;2015:826124. doi: 10.1155/2015/826124. Epub 2015 Nov 30.

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies.

Sarcoma

Jody E Hooper, Emma L Cantor, Macgregor S Ehlen, Avirup Banerjee, Suman Malempati, Peter Stenzel, Randy L Woltjer, Regina Gandour-Edwards, Neal C Goodwin, Yan Yang, Pali Kaur, Carol J Bult, Susan D Airhart, Charles Keller

Affiliations

  1. Department of Pathology, Johns Hopkins Medicine, 600 N. Wolfe Street, Pathology B-106, Baltimore, MD 21287, USA.
  2. Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA ; Department of Pediatrics, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.
  3. Department of Pediatrics, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.
  4. Department of Pathology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.
  5. University of California Davis School of Medicine and Cancer Center, Sacramento, CA 95817, USA.
  6. The Jackson Laboratory, 1650 Santa Ana Avenue, Sacramento, CA 95838, USA ; Champions Oncology, Hackensack, NJ 07601, USA.
  7. The Jackson Laboratory, 1650 Santa Ana Avenue, Sacramento, CA 95838, USA ; Leo Universal, Inc., Torrance, CA 90505, USA.
  8. The Jackson Laboratory, 1650 Santa Ana Avenue, Sacramento, CA 95838, USA.
  9. Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA ; Department of Pediatrics, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA ; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.

PMID: 26696773 PMCID: PMC4677247 DOI: 10.1155/2015/826124

Abstract

Embryonal rhabdomyosarcoma (eRMS) is one of the most common soft tissue sarcomas in children and adolescents. Parameningeal eRMS is a variant that is often more difficult to treat than eRMS occurring at other sites. A 14-year-old female with persistent headaches and rapid weight loss was diagnosed with parameningeal eRMS. She progressed and died despite chemotherapy with vincristine, actinomycin-D, and cyclophosphamide plus 50.4 Gy radiation therapy to the primary tumor site. Tumor specimens were acquired by rapid autopsy and tumor tissue was transplanted into immunodeficient mice to create a patient-derived xenograft (PDX) animal model. As autopsy specimens had an ALK R1181C mutation, PDX tumor bearing animals were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth, suggesting that single agent kinase inhibitor therapy may be insufficient in similar cases. This unique parameningeal eRMS PDX model is publicly available for preclinical study.

References

  1. Cancer. 2009 Sep 15;115(18):4218-26 - PubMed
  2. Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20002-7 - PubMed
  3. BMC Bioinformatics. 2007 Feb 08;8:48 - PubMed
  4. Pediatr Blood Cancer. 2013 Feb;60(2):173-4 - PubMed
  5. Clin Cancer Res. 2010 Mar 1;16(5):1478-85 - PubMed
  6. Bioinformatics. 2012 Jun 15;28(12):i172-8 - PubMed
  7. Cancer Cell. 2013 Dec 9;24(6):710-24 - PubMed
  8. Ann Oncol. 2014 Jan;25(1):231-6 - PubMed
  9. Nat Biotechnol. 2011 Oct 30;29(11):1046-51 - PubMed
  10. PLoS One. 2011;6(8):e23498 - PubMed
  11. Genome Res. 2007 Nov;17(11):1665-74 - PubMed
  12. Cancer Discov. 2014 Feb;4(2):216-31 - PubMed
  13. Genome Res. 2010 Sep;20(9):1297-303 - PubMed
  14. Methods Mol Biol. 2012;802:57-72 - PubMed
  15. Cancer Cell. 2011 Feb 15;19(2):177-91 - PubMed
  16. Contemp Oncol (Pozn). 2015;19(2):98-107 - PubMed
  17. Bioinformatics. 2004 Feb 12;20(3):307-15 - PubMed
  18. Cell Rep. 2013 Nov 27;5(4):933-40 - PubMed
  19. Genes Chromosomes Cancer. 2002 Mar;33(3):310-21 - PubMed
  20. Nucleic Acids Res. 2015 Jan;43(Database issue):D818-24 - PubMed
  21. Nat Genet. 2011 May;43(5):491-8 - PubMed
  22. Cancer Cell. 2012 Oct 16;22(4):536-46 - PubMed
  23. Front Oncol. 2015 Apr 01;5:74 - PubMed
  24. Bioinformatics. 2009 Nov 1;25(21):2865-71 - PubMed
  25. Pediatr Blood Cancer. 2012 Jul 15;59(1):5-10 - PubMed
  26. PLoS One. 2012;7(2):e30619 - PubMed
  27. Sarcoma. 2012;2012:406239 - PubMed
  28. Int J Surg Pathol. 2009 Feb;17 (1):22-30 - PubMed
  29. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):635-42 - PubMed
  30. Histol Histopathol. 2004 Apr;19(2):401-11 - PubMed
  31. Pediatr Blood Cancer. 2014 Sep;61(9):1570-7 - PubMed
  32. Pediatr Blood Cancer. 2013 Feb;60(2):204-9 - PubMed
  33. J Clin Oncol. 2009 Nov 1;27(31):5182-8 - PubMed
  34. Bioinformatics. 2009 Jul 15;25(14):1754-60 - PubMed
  35. Nat Rev Cancer. 2015 Jul;15(7):426-39 - PubMed
  36. Am J Pathol. 2009 Feb;174(2):550-64 - PubMed
  37. Genes Dev. 2014 Jul 15;28(14 ):1578-91 - PubMed
  38. Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5 - PubMed

Publication Types

Grant support